Latest filing published 03 Nov 2026 for Artiva Biotherapeutics, Inc., €4,154.
Filing timeline
BuySaleInsider track record
Subhashis Banerjee: trading record in brief
Subhashis Banerjee appears in our data through filings on Artiva Biotherapeutics, Inc. shares, published by SEC (Form 4). In total, 10 filings cover trades dated from 8 April 2025 to 2 November 2026.
No open-market purchase appears, only 5 sales worth €111k. Outside the open market, there are 3 share grants and 2 option exercises. 2026 to date brings no purchases and 5 sales.
On 3 November 2026 came the latest disclosure, an open-market sale for €4,154 in Artiva Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Subhashis Banerjee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,110 shares@ US$4.1811Common StockSEC:0001193125-26-445314:0
- 1,099 shares@ US$6.83720.0022% mcap5.8% of flowCommon StockSEC:0001193125-26-415528:0
- 30,000 shares0Common StockSEC:0001193125-26-389510:0
- 1,100 shares@ US$11.15560.0039% mcap9.1% of flowCommon StockSEC:0001193125-26-383619:0
- 8,222 shares@ US$12.00870.045% mcap73.1% of flowCommon StockSEC:0001193125-26-377207:1
- 5,306 shares@ US$1.920.0047% mcap7.5% of flowCommon StockSEC:0001193125-26-377207:0
- 429 shares@ US$1.920.0004% mcap0.6% of flowCommon StockSEC:0001193125-26-357383:0
- 429 shares@ US$12.000.0024% mcap3.8% of flowCommon StockSEC:0001193125-26-357383:1
- 102,000 shares0Common StockSEC:0001193125-26-057668:0
- 50,000 shares0Common StockSEC:0001415889-25-011379:0
10 of 10 declarations